APA (7th ed.) Citation

YK, G., EA, B., A, W., B, M., G, H., J, W., . . . P, S. (2019). PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors. Clinical and experimental medicine, 19(2), 201. https://doi.org/10.1007/s10238-018-0541-2

Chicago Style (17th ed.) Citation

YK, Gebreyohannes, et al. "PLX9486 Shows Anti-tumor Efficacy in Patient-derived, Tyrosine Kinase Inhibitor-resistant KIT-mutant Xenograft Models of Gastrointestinal Stromal Tumors." Clinical and Experimental Medicine 19, no. 2 (2019): 201. https://doi.org/10.1007/s10238-018-0541-2.

MLA (9th ed.) Citation

YK, Gebreyohannes, et al. "PLX9486 Shows Anti-tumor Efficacy in Patient-derived, Tyrosine Kinase Inhibitor-resistant KIT-mutant Xenograft Models of Gastrointestinal Stromal Tumors." Clinical and Experimental Medicine, vol. 19, no. 2, 2019, p. 201, https://doi.org/10.1007/s10238-018-0541-2.